Target intelligence / Profile preview

23S ribosomal RNA peptidyl transferase center (PTC) (PTC)

Target
PTC
Molecular classification
Ribozyme, Ribosomal RNA, Enzyme
01

Overview

The 23S ribosomal RNA (rRNA) peptidyl transferase center (PTC) is the catalytic core of the bacterial 50S ribosomal subunit, functioning as a ribozyme that facilitates peptide bond formation (Polacek & Mankin, 2005, Crit Rev Biochem Mol Biol). It plays a fundamental role in translation by orienting the 3' ends of A-site and P-site tRNAs to allow the nucleophilic attack of the aminoacyl-tRNA on the peptidyl-tRNA. Due to its vital role in bacterial growth and its structural divergence from eukaryotic cytoplasmic ribosomes, the PTC is a major target for diverse classes of antibiotics, including oxazolidinones, macrolides, and lincosamides (Wilson, 2014, Cold Spring Harb Perspect Med). These agents interfere with protein synthesis by either directly inhibiting the peptidyl transferase reaction or by sterically hindering the passage of the growing polypeptide chain through the exit tunnel. Clinical challenges associated with targeting the PTC include the emergence of resistance through rRNA methylation or mutations and potential off-target effects on human mitochondrial ribosomes (Vester & Douthwaite, 2001, Antimicrob Agents Chemother). Consequently, the PTC remains a focal point for the design of novel antimicrobial agents aimed at overcoming drug-resistant pathogens.

Other names
Peptidyl transferase center50S ribosomal subunit peptidyl transferase center23S rRNA PTCRibozyme centerDomain V of 23S rRNA
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 23S rRNA within the 50S ribosomal subunit, thereby blocking peptide bond formation or obstructing the nascent peptide exit tunnel (Wilson, 2014, Cold Spring Harb Perspect Med).

03

Biological functions

Protein synthesisPeptide bond formationTranslation
04

Disease associations

Infection
05

Safety considerations

Mitochondrial protein synthesis inhibitionMyelosuppressionAntibiotic resistance developmentGastrointestinal side effectsSerotonin syndrome (with oxazolidinones)
06

Interacting drugs

Chloramphenicol

13 more in the full profile.

07

Biomarkers

23S rRNA mutations (e.g., A2058G, G2576T)cfr methyltransferase gene expressionerm methylase gene expression

Beyond the preview

Go deeper on 23S ribosomal RNA peptidyl transferase center (PTC) (PTC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 23S ribosomal RNA peptidyl transferase center (PTC) (PTC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call